The global atopic dermatitis clinical trials market was valued at USD 2.85 Billion in 2023, which is anticipated to grow at a CAGR of 12.73% from 2024 to 2033. The drivers propelling the market expansion include tec...
The global corneal implants market was valued at USD 439.8 million in 2023, growing at a CAGR of 6.1% from 2024 to 2033. The market is expected to reach USD 795.0 million by 2033. The rising prevalence of corneal disease...
The global mitral valve disease market was valued at USD 3.2 billion in 2023, growing at a CAGR of 9.1% from 2024 to 2033. The market is expected to reach USD 7.6 billion by 2033. The market is driven by the increasing i...
The global invisible orthodontics market was valued at USD 5.8 billion in 2023, growing at a CAGR of 21.7% from 2024 to 2033. The market is expected to reach USD 41.3 billion by 2033. The growing desire for cosmetic dent...
The global molecular biology enzymes market was valued at USD 15.7 billion in 2022, growing at a CAGR of 14.5% from 2023 to 2032. The market is expected to reach USD 60.8 billion by 2032. The growing prevalence of geneti...
The global antidepressants drugs market was valued at USD 17.02 billion in 2022 and growing at a CAGR of 7.90% from 2023 to 2032. The market is expected to reach USD 36.41 billion by 2032. Antidepressants are professiona...
The global spatial OMICS market was valued at USD 300 million in 2022 and grew at a CAGR of 10% from 2023 to 2032. The market is expected to reach USD 778.12 million by 2032. The growing applications of spatial OMICS in ...
The global antacids market was valued at USD 7 billion in 2022 and grew at a CAGR of 4% from 2023 to 2032. The market is expected to reach USD 10.36 billion by 2032. The increasing prevalence of acidity, heartburn and ot...
The global sickle cell disease treatment market was valued at USD 2 billion in 2022 and grew at a CAGR of 20% from 2023 to 2032. The market is expected to reach USD 12.38 billion by 2032. The increasing prevalence of sic...
The global epilepsy drugs market was valued at USD 10 billion in 2022 and grew at a CAGR of 4% from 2023 to 2032. The market is expected to reach USD 14.80 billion by 2032. The increasing prevalence of epilepsy will driv...
Page 6 of 46